Eudaimonia Partners’s Labcorp LH Stock Holding History

Eudaimonia Partners’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-116	Closed	-$26K	–	935
2021 Q1	$26K	Hold	116	–	–	0.01%	861
2020 Q4	$20K	Buy	+116	New	+$20K	﹤0.01%	870

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

MCM

Melvin Capital Management New York $9.86B AUM 16.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Eudaimonia Partners's LH Position: Q2 2021 in Review

Eudaimonia Partners sold out of Labcorp (LH) in Q2 2021, closing a stake of 116 shares — an estimated $26K sold.

Eudaimonia Partners first reported a position in LH in Q4 2020 and held it in 2 quarters. The position peaked at $26K in Q1 2021. 948 funds tracked by Wall St. Rank hold LH as of Q2 2021.

Eudaimonia Partners reported no remaining Labcorp position as of Q2 2021 after selling out during the quarter.
Eudaimonia Partners sold 116 Labcorp shares in Q2 2021, an estimated $26K.
Eudaimonia Partners first reported a position in Labcorp in Q4 2020 and held it in 2 quarters.
Eudaimonia Partners's Labcorp position peaked at $26K in Q1 2021.
948 funds tracked by Wall St. Rank held Labcorp as of Q2 2021.

Based on Eudaimonia Partners's 13F filing for Q2 2021, filed 13 Aug 2021.